CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Milano, Italy and 80 other locations
Self-management strategies for asthma, including patients engagement and adherence to personalised action plans with advice on recognizing a...
Pavia, Italy and 8 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.The study duration will be up to 37 weeks including an investigati...
Phase 3
Pavia, PV, Italy and 45 other locations
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...
Phase 3
Milano, Lombardia, Italy and 141 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Milano, Italy and 350 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Milano, Lombardia, Italy and 429 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Milano, Italy and 180 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Milano, Italy and 477 other locations
profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studi...
Phase 3
Rozzano (MI), Lombardia, Italy and 128 other locations
(MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged 12 years and above with asthma...
Phase 3
Milano, Lombardia, Italy and 83 other locations
Clinical trials
Research sites
Resources
Legal